|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/497 | (2013.01) |
| C07D 401/12 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/496 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| C07D 401/12 | (2013.01) | ||
| A61K 31/4196 | (2013.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 31/454 | (2013.01) | ||
| A61K 31/498 | (2013.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/00 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3333164 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17189480.1 |
| Date of filing the European patent application | 2012-07-26 | |
| (97) | Date of publication of the European application | 2018-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161513428 P | 2011-07-29 | US | |
| 201161513432 P | 2011-07-29 | US | |
| 201261610178 P | 2012-03-13 | US | |
| 201261653588 P | 2012-05-31 | US | |
| 201261654651 P | 2012-06-01 | US |
| (72) |
Sandanayaka,, Vincent P , US
Shacham,, Sharon , US
McCauley, Dilara , US
Shechter, Sharon , US
|
| (73) |
Karyopharm Therapeutics Inc. ,
85 Wells Avenue, Newton, MA 02459,
US
|
| (54) | HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF |
| HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF |